Endometriosis and chronic pain: a multispecialty roundtable discussion.
Levy
Barbara S
BS
Women's Health Center, Franciscan Health System, Federal Way, Wash, USA.
Apgar
Barbara S
BS
Surrey
Eric S
ES
Wysocki
Susan
S
D000282:Administration, Intravaginal; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis; D002097:C-Reactive Protein / Q000032:analysis; D017115:Catheter Ablation; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003271:Contraceptive Agents, Female / Q000627:therapeutic use; D003613:Danazol / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004715:Endometriosis / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D004965:Estrogen Antagonists / Q000008:administration & dosage; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists / Q000627:therapeutic use; D006801:Humans; D007247:Infertility, Female / Q000209:etiology; D010535:Laparoscopy; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D017699:Pelvic Pain / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D017410:Practice Guidelines as Topic; D012086:Reoperation; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D015415:Biomarkers; D003271:Contraceptive Agents, Female; D004965:Estrogen Antagonists; D007987:Gonadotropin-Releasing Hormone; D002097:C-Reactive Protein; D017258:Medroxyprogesterone Acetate; D003613:Danazol